Barely Significant
← all excerpts

Antibodies to watch in 2021.

MAbs · 2021 · PMC7833761 · PMID 33459118

Europe PMCDOI
2
hedged sentences
—
closest p
—
boldest claim

The sentences

nominally significantno p-value reported
Fasinumab 1 mg monthly also showed nominally significant benefits in physical function in both trials and pain in FACT OA2, when compared to the maximum FDA-approved prescription doses of NSAIDs for OA.

also in 7,732 other papers

did not reach statistical significanceno p-value reported
The alternate drug treatment arm of FACT OA1, fasinumab 1 mg every 2 months showed numerical benefit over placebo, but did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.